157 related articles for article (PubMed ID: 2694474)
1. New techniques in antivenom production and active immunization against snake venoms.
Theakston RD
Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
[No Abstract] [Full Text] [Related]
2. Synthetic biology tackles global antivenom shortage.
Arnold C
Nature; 2016 Apr; 532(7599):292. PubMed ID: 27111610
[No Abstract] [Full Text] [Related]
3. [Avidity of sera-neutralizing snake venom].
Abidov AA; Lisochenko LG; Zaidova SM
Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):115-8. PubMed ID: 665016
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
[TBL] [Abstract][Full Text] [Related]
5. Snake venoms in science and clinical medicine. 2. Applied immunology in snake venom research.
Theakston RD
Trans R Soc Trop Med Hyg; 1989; 83(6):741-4. PubMed ID: 2617643
[TBL] [Abstract][Full Text] [Related]
6. Venoms, antivenoms and immunotherapy.
Chippaux JP; Goyffon M
Toxicon; 1998 Jun; 36(6):823-46. PubMed ID: 9663690
[TBL] [Abstract][Full Text] [Related]
7. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
Seddik SS; Wanas S; Helmy MH; Hashem M
J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM
Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735
[TBL] [Abstract][Full Text] [Related]
9. [Role of antivenoms in the treatment of snake envenomation].
Chippaux JP
Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
[TBL] [Abstract][Full Text] [Related]
10. Immune response towards snake venoms.
León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
[TBL] [Abstract][Full Text] [Related]
11. [Exotic snake bites in Switzerland].
Stadelmann M; Ionescu M; Chilcott M; Berney JL; Gétaz L
Rev Med Suisse; 2010 May; 6(248):969-72. PubMed ID: 20545262
[TBL] [Abstract][Full Text] [Related]
12. Snake antivenom: Challenges and alternate approaches.
Alangode A; Rajan K; Nair BG
Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
[TBL] [Abstract][Full Text] [Related]
13. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
[TBL] [Abstract][Full Text] [Related]
14. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
Laing GD; Renjifo JM; Ruiz F; Harrison RA; Nasidi A; Gutierrez JM; Rowley PD; Warrell DA; Theakston RD
Toxicon; 2003 Jul; 42(1):35-41. PubMed ID: 12893059
[TBL] [Abstract][Full Text] [Related]
15. Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization.
Zolfagharian H; Dounighi NM
Hum Vaccin Immunother; 2015; 11(11):2734-9. PubMed ID: 25700656
[TBL] [Abstract][Full Text] [Related]
16. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
Chinzei H
Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
[No Abstract] [Full Text] [Related]
17. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.
Ratanabanangkoon K; Tan KY; Eursakun S; Tan CH; Simsiriwong P; Pamornsakda T; Wiriyarat W; Klinpayom C; Tan NH
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004565. PubMed ID: 27058956
[TBL] [Abstract][Full Text] [Related]
18. Antivenom activity of rattlesnake blood plasma.
Straight R; Glenn JL; Snyder CC
Nature; 1976 May; 261(5557):259-60. PubMed ID: 1272402
[No Abstract] [Full Text] [Related]
19. Humoral immune responses to venom and antivenom of patients bitten by Bothrops snakes.
Morais V; Berasain P; Ifrán S; Carreira S; Tortorella MN; Negrín A; Massaldi H
Toxicon; 2012 Feb; 59(2):315-9. PubMed ID: 22206812
[TBL] [Abstract][Full Text] [Related]
20. A focus on snake venoms and antivenins.
Schaer M
J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):458-60. PubMed ID: 22316193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
